XML 67 R47.htm IDEA: XBRL DOCUMENT v3.5.0.2

Equity Method Investments (Tables)

12 Months Ended

Sep. 01, 2016

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Equity Method Investments

As of		2016							2015
		Investment Balance				Ownership Percentage			Investment Balance				Ownership Percentage
Inotera		$	1,314			33	%		$	1,332			33	%
Tera Probe		36				40	%		38				40	%
Other		14				Various			9				Various
		$	1,364						$	1,379

As of September 1, 2016, substantially all of our maximum exposure to loss from our VIEs that were not consolidated was the $1.31 billion carrying value of our investment in Inotera.  We may also incur losses in connection with our rights and obligations to purchase all of Inotera's wafer production capacity under our supply agreement with Inotera.

We recognize our share of earnings or losses from our equity method investees generally on a two-month lag.  Included in our share of earnings for 2015 was $49 million related to Inotera's full release of its valuation allowance against net deferred tax assets related to its net operating loss carryforward and the resulting tax provision in subsequent periods. Equity in net income (loss) of equity method investees, net of tax, included the following:

For the year ended		2016				2015				2014
Inotera		$	32			$	445			$	465
Tera Probe		(11		)		1				11
Other		4				1				(2		)
		$	25			$	447			$	474

The summarized financial information in the tables below reflects aggregate amounts for our equity method investees. Financial information is presented for equity method investments as of the respective dates and for the periods through which we recorded our proportionate share of each investee's results of operations. Summarized results of operations are presented only for the periods subsequent to the acquisition, or through the disposition of, our ownership interests.

As of		2016				2015
Current assets		$	1,222			$	1,980
Noncurrent assets		4,294				3,038
Current liabilities		604				436
Noncurrent liabilities		411				119

For the year ended		2016				2015				2014
Net sales		$	1,671			$	2,647			$	3,382
Gross margin		155				1,253				1,576
Operating income		199				1,191				1,371
Net income		184				1,361				1,339

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=66011266&loc=d3e33918-111571

+ Details

Name:	us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration